Ironwood Pharmaceuticals 2019 J.P. Morgan Healthcare Conference

Ironwood Pharmaceuticals presented at the J.P. Morgan Healthcare Conference in January 2019, detailing plans to grow its LINZESS gastrointestinal franchise and accelerate U.S. GI development portfolio. The company outlined its strategy to deliver profits beginning in 2019 following a planned separation and establish itself as a profitable, GI-focused healthcare company leveraging its expertise in innovative therapies.